Drug Enforcement Administration January 2005 – Federal Register Recent Federal Regulation Documents

Ray V. Surapaneni, D.O.; Revocation of Registration
Document Number: 05-1326
Type: Notice
Date: 2005-01-25
Agency: Drug Enforcement Administration, Department of Justice
James E. Thomas, M.D., Revocation of Registration
Document Number: 05-1325
Type: Notice
Date: 2005-01-25
Agency: Drug Enforcement Administration, Department of Justice
Al-Alousi, Inc., Denial of Registration
Document Number: 05-1324
Type: Notice
Date: 2005-01-25
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-1285
Type: Notice
Date: 2005-01-25
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-1284
Type: Notice
Date: 2005-01-25
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-1283
Type: Notice
Date: 2005-01-25
Agency: Drug Enforcement Administration, Department of Justice
Solicitation of Comments on Dispensing of Controlled Substances for the Treatment of Pain
Document Number: 05-906
Type: Notice
Date: 2005-01-18
Agency: Drug Enforcement Administration, Department of Justice
On November 16, 2004, DEA published in the Federal Register an Interim Policy Statement on the dispensing of controlled substances for the treatment of pain. The Interim Policy Statement stated that DEA would address the subject in greater detail in a future Federal Register document, taking into consideration the views of the medical community. DEA is hereby seeking comments from physicians and other interested members of the public as to what areas of the law relating to the dispensing of controlled substances for the treatment of pain they would like DEA to address in the upcoming Federal Register document.
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-77
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-76
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 05-75
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-74
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 05-73
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-72
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-70
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-69
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-68
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-67
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-66
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-65
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-64
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-63
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-62
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 05-61
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 05-60
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 05-59
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 05-58
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Exemption of Chemical Mixtures; Correction
Document Number: 05-57
Type: Rule
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
This document corrects the Final Rule with request for comment ``Exemption of Chemical Mixtures'' [Docket No. DEA-137f2, RIN 1117- AA31] which DEA published in the Federal Register on Wednesday, December 15, 2004 (69 FR 74957). The Final Rule concerned the exemption of certain chemical mixtures containing listed chemicals from the provisions of the Controlled Substances Act.
Recordkeeping and Reporting Requirements for Drug Products Containing Gamma-Hydroxybutyric Acid (GHB)
Document Number: 05-56
Type: Rule
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
DEA is amending its regulations to require additional recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB) for which an application has been approved under the Federal Food, Drug, and Cosmetic Act. DEA makes these changes under section 4 of the ``Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000.'' These additional requirements are necessary to protect against the diversion of GHB for illicit purposes.
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-52
Type: Notice
Date: 2005-01-04
Agency: Drug Enforcement Administration, Department of Justice
Controlled Substances: Established Initial Aggregate Production Quotas for 2005
Document Number: 04-28746
Type: Notice
Date: 2005-01-03
Agency: Drug Enforcement Administration, Department of Justice
This notice establishes initial 2005 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.